Mr. White is the Chairman and Chief Executive Officer of Spectra, a multi-family and student housing developer. He was previously CEO of Invesque.
Prior to Invesque, he was Executive Vice President of HealthLease Properties, a publicly traded REIT focused on health care real estate. He also previously served as a Senior Vice President of Brookfield Asset Management Inc., where he was responsible for raising capital for various alternative asset vehicles across real estate, private equity and infrastructure.
His career experience includes a tenure as Director and Head of Deal Management at Citigroup’s Alternatives Distribution Group.
Earlier in his career, Mr. White was part of the Health Care Group at Citi’s Investment Bank, working with clients in the healthcare sector on M&A and capital raising assignments. He began his career in public accounting as an auditor for PricewaterhouseCoopers.
Mr. White earned a Bachelor’s Degree with highest honors in Political Science and Journalism from Rutgers University. He received his Master’s of Business Administration from Rutgers Graduate School of Management and his law degree from the University of Pennsylvania Law School. Mr. White is a member of the Board of Directors of Rutgers University Foundation and a member of the Board of the NJ Chapter of Young Presidents ’Organization (YPO).
Mr. Benbow is the Chairman and Chief Executive Officer of Prolific. With over 40 years of revenue, media and marketing experience and a nationally recognized growth strategist, Mr. Benbow regularly advises some of the fastest-growing organizations in the United States. Mr. Benbow also co-founded Prolific portfolio companies, JDA Worldwide and Conquer.
Mr. Benbow graduated from Wabash College where he earned a Bachelor’s Degree in Economics. Mr. Benbow started his career with Ackerman & McQueen in Dallas, Texas, and went on to co-found Rutter Communications Network, the leading cable advertising rep firm in the U.S., before selling the firm to Comcast in 2009. He currently serves on the board of directors for both Answers in Genesis and Biglife.
Chair of Compensation and Human Resources Committee and Governance and Nominating Committee member.
Mr. Chester’s career spans more than 20 years, with experience in finance, real estate, investments, development, and capital markets. Over the course of Mr. Chester’s career, he has initiated billions in successful capital raises, lead numerous tactical acquisitions and created billions of dollars in value through strategic divestitures.
Mr. Chester has established himself as a leader in the health care industry and has meaningful partnerships and relationships with operators and developers throughout the senior care industry. Prior to his position as Chief Executive Officer of Invesque, he has also served as the company’s Chief Financial Officer and Chief Investment Officer throughout his tenure. Mr. Chester was critical to the successful launch and IPO of HealthLease Properties. In the role of Chief Financial Officer, he grew HealthLease Properties from a $250 million company to nearly $1 billion. In 2014, he orchestrated the multi-billion dollar sale and development capital deal with Welltower (NYSE:WELL). Mr. Chester’s success helped earn the coveted title of CFO of the Year by Indianapolis Business Journal in 2014, and a spot on the 2015 Forty Under 40 list by Indianapolis Business Journal.
Mr. Hawkins is the founder of the ProSyte Companies, a diversified holding entity investing in businesses and real estate in the United States Midwest, as well as communications and infrastructure entities in West Africa.
From 2012 until his departure in 2015, Mr. Hawkins was Vice President of New Ventures and Private Equity Investing at Eli Lilly (NYSE: LLY). In this capacity, Mr. Hawkins was responsible for Eli Lilly’s venture capital, private equity and venture formation activities, managing over $1.4 billion. Mr. Hawkins joined Eli Lilly in 2001 and held various roles in sales and corporate business development at the company. In 2010, Mr. Hawkins was promoted to Chief Diversity Officer to lead the development and implementation of Eli Lilly’s global diversity and inclusion strategy.
Mr. Hawkins graduated magna cum laude with a Bachelor’s Degree from the University of Tennessee in 1995, and earned a Master’s of Business Administration from the Kellogg School of Management at Northwestern University in 2000.
Chair of the Governance and Nominating Committee and Audit Committee member.
Ms. Steinel is a veteran of the industry with over 30 years of experience in global consulting. Currently, she provides consulting services and leadership development to executives at various organizations.
Ms. Steinel is a member of the board of trustees of Federal Realty Investment Trust (NYSE: FRT), a member of the board of directors until February 2020 of MTS Systems Corporation (NASDAQ: MTSC) and a member of the board of DAI. She currently serves on the audit committees for each of the boards and is the chairperson of the Federal Realty Investment Trust Audit Committee. She is also the chairperson of the Compensation Committee for DAI and was the chairperson of the Nomination & Governance Committee for MTS.
Ms. Steinel spent over 20 years at Arthur Andersen and was the Global Managing Partner of the Business Consulting Group, one of the fastest-growing consultancies in the world, with $2.5 billion revenue, 10,000 employees, and operations in 85 countries when the business was sold to BearingPoint in 2002. She retired from BearingPoint in February 2007 after five years as EVP of Global Commercial Services.
Ms. Steinel has twice been recognized as one of Consulting Magazine’s Top 25 Consultants and has attended Fortune’s Most Powerful Women in Business Summit. Ms. Steinel graduated as an accounting major from Rutgers University in 1979 and is a certified public accountant.
Chair of Audit Committee and Governance and Nominating Committee member.